Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels

Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

(2013) T. Baglin et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Plasma-Diluted Thrombin Time to Measure Dabigatran Concentrations During Dabigatran Etexilate Therapy

(2012) Scott T. Avecilla et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran

(2012) Joanne van Ryn et al.   AMERICAN JOURNAL OF MEDICINE

Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran

(2012) Joachim Stangier et al.   BLOOD COAGULATION & FIBRINOLYSIS

Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology

(2012) Trevor Baglin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Impact of dabigatran on a large panel of routine or specific coagulation assays

(2012) Séverine Robert et al.   THROMBOSIS AND HAEMOSTASIS

Dabigatran Falsely Elevates Point of Care International Normalized Ratio Results

(2011) Christina E. DeRemer et al.   AMERICAN JOURNAL OF MEDICINE

Potential Inaccuracy of Point-of-Care INR in Dabigatran-Treated Patients

(2011) Lawrence Baruch et al.   ANNALS OF PHARMACOTHERAPY

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin

(2011) Joachim Stangier et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects after oral administration of dabigatran etexilate

(2011) Norio Yamamura et al.   THROMBOSIS AND HAEMOSTASIS

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

(2010) Joachim Stangier et al.   THROMBOSIS AND HAEMOSTASIS

Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays

(2010) Fariba Baghaei et al.   THROMBOSIS AND HAEMOSTASIS

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate

(2008) Joachim Stangier   CLINICAL PHARMACOKINETICS